As lawmakers worldwide grow more concerned about the use and circulation of disposable vapes, PMI has launched VEEBA, a new disposable vape device available in nine flavours. The tobacco company explains that VEEBA’s e-liquid is made from pharma-grade nicotine and food-grade flavourings, and emits on average over 99% lower levels of harmful chemicals compared to cigarettes.
Given the growing concern surrounding the unsustainability of disposable devices, PMI has set in place the VEEBA Recycling Programme, which encourages users to dispose of used devices in a responsible and sustainable manner. This is done by enabling the cleaning and separation of the different component of the devices so that manufacturers can then reuse them to make new products.
Head of commercial planning for PML, Kate O’Dowd, discussed the sustainable nature of the product. “VEEBA demonstrates that a responsible disposable e-vapour device can fulfil the needs of existing adult nicotine users and generate returns for retailers, all while striving for excellence in quality, compliance, and sustainability. Retailers can feel assured that by listing VEEBA, they are stocking a smoke-free product that adheres to local laws and in many cases, strives to go even further.”
PMI branches out into the wellness industry
On promoting the company’s safer nicotine alternative products, last year, PMI CEO Jacek Olzak reiterated the company’s plan to branch out into wellness. When asked about PMI’s plans to expand into wellness and healthcare areas, Olzak said that this is a natural evolution process for the tobacco company. “This is a natural evolution for PMI to further transform our business into a broader lifestyle, consumer wellness and healthcare company in the future. It is an evolution that will deliver not only on our continued commitment to achieve a smoke-free future, but also in developing and commercializing scientifically substantiated products and solutions that meet unmet consumer and patient needs.”
He added that the market is ready for these changes. “The market for wellness and healthcare products is large and growing. We have several focus areas in our pipeline. For consumer and over-the-counter wellness products, we have several initiatives looking at focus, sleep, energy, pain and calm. In healthcare, we believe there are significant unmet patient needs for fast and effective treatments in cardiovascular, such as myocardial infarction, and neurology, such as migraine, which can be served by innovative solutions. We have recently accelerated this part of our strategy with the acquisition of Vectura, a provider of innovative inhaled drug-delivery solutions, and Fertin, a leading developer and manufacturer of innovative pharmaceutical and well-being products based on oral and intra-oral delivery systems,” said Olzak.
Olzak also believes that, in addition to existing efforts to stop people from starting smoking and to help them quit, offering smoke-free alternatives to adults who choose to continue smoking can also have a positive impact on public health. In this context, he calls on the authorities, policymakers and public health groups to act accordingly.
Read Further: The Grocer
PMI and Medicago End Partnership Following Covid-19 Vaccine Rejection
